Arecor Therapeutics plc (AIM:AREC)
United Kingdom · Delayed Price · Currency is GBP · Price in GBX 77.50
0.00 (0.00%)
Nov 5, 2026, 9:39 AM GMT
Arecor Therapeutics Market Cap
Arecor Therapeutics has a market cap or net worth of 35.11 million as of November 5, 2026. It is the 30,201st most valuable company in the world and the 675th biggest in the United Kingdom. Its market cap has increased by 28.26% in one year.
Market Cap
35.11M
Enterprise Value
32.01M
Revenue
890.00K
Global Rank
Country Rank
#675 United Kingdom
PE Ratio
154.01
ChartMarket Cap Chart
Since June 3, 2021, Arecor Therapeutics's market cap has decreased from 66.99M to 35.11M, a decrease of -47.60%. That is a compound annual growth rate of -11.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2026 | 35.11M | 15.51% |
| Dec 31, 2025 | 30.39M | 9.52% |
| Dec 31, 2024 | 27.75M | -50.35% |
| Dec 29, 2023 | 55.89M | -23.94% |
| Dec 30, 2022 | 73.48M | -34.00% |
| Dec 31, 2021 | 111.34M | 66.19% |
| Jun 3, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Scancell Holdings | 103.19M |
| 4basebio | 81.62M |
| Faron Pharmaceuticals Oy | 64.65M |
| Ondine Biomedical | 52.19M |
| Poolbeg Pharma | 47.20M |
| Hemogenyx Pharmaceuticals | 38.57M |
| IXICO | 32.85M |
| Sareum Holdings | 24.85M |